News
MYO
4.430
+3.26%
0.140
Myomo Announces Board Transition with Director Departures
TipRanks · 3d ago
*Myomo: Directors Amy Knapp and Yitzchak Jacobovitz Won't Stand for Re-election >MYO
Dow Jones · 3d ago
Myomo: Balancing CMS Tailwinds With Long-Term Risks
Seeking Alpha · 4d ago
Weekly Report: what happened at MYO last week (0331-0404)?
Weekly Report · 6d ago
Myomo to Present at the 24th Annual Needham Virtual Healthcare Conference
Barchart · 03/31 15:05
Weekly Report: what happened at MYO last week (0324-0328)?
Weekly Report · 03/31 11:22
Weekly Report: what happened at MYO last week (0317-0321)?
Weekly Report · 03/24 11:10
Weekly Report: what happened at MYO last week (0310-0314)?
Weekly Report · 03/17 11:21
Myomo Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 03/12 11:20
Myomo Price Target Raised to $9.50/Share From $7.50 by HC Wainwright & Co.
Dow Jones · 03/12 11:20
HC Wainwright & Co. Maintains Buy on Myomo, Raises Price Target to $9.5
Benzinga · 03/12 11:09
Myomo Is Maintained at Buy by Craig-Hallum
Dow Jones · 03/11 13:39
Craig-Hallum Maintains Buy on Myomo, Raises Price Target to $11
Benzinga · 03/11 13:29
Myomo Reports Record Revenue and Positive Cash Flow
TipRanks · 03/11 03:54
MYOMO, INC. 2024 FORM 10-K ANNUAL REPORT
Press release · 03/10 22:31
Myomo, Inc. (MYO) Reports Q4 Loss, Tops Revenue Estimates
NASDAQ · 03/10 21:15
Myomo jumps 20% to $5.02 after Q4 results, above-consensus guidance
TipRanks · 03/10 20:20
Myomo reports Q4 EPS (1c), consensus (2c)
TipRanks · 03/10 20:17
Myomo sees Q1 revenue $9.0M-$9.5M, consensus $7.9M
TipRanks · 03/10 20:16
Myomo GAAP EPS of -$0.01 beats by $0.01, revenue of $12.07M beats by $2.17M
Seeking Alpha · 03/10 20:07
More
Webull provides a variety of real-time MYO stock news. You can receive the latest news about Myomo through multiple platforms. This information may help you make smarter investment decisions.
About MYO
More
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.